Menu

The 2018 Governor's Conference on Effective Partnering in Cancer Research



April 19, 2018

THE ROLE OF P53 IN LI-FRAUMENI SYNDROME

Wolfensohn Hall, Institute for Advanced Study
Princeton, NJ

Speakers:

8:55 am - 9:00 am
   
WELCOMING REMARKS
      
9:00 am - 10:00 am
Shelley L. Berger, PhD

University of Pennsylvania
Epigenetic pathways in cancer and in cancer immunotherapy

10:00 am - 11:00 am
Chang S. Chan, PhD

Rutgers Cancer Institute of New Jersey
Tumorigenesis and penetrance in Li-Fraumeni Syndrome

11:00 am - 11:30 am
    BREAK - Bloomberg Hall Biology Atrium

11:30 am - 12:30 pm
Hugues de Thé, MD, PhD

Collège de France
P53-driven acute promyelocytic leukemia cure by retinoic acid and arsenic

12:30 pm - 2:00 pm
    LUNCH - Available in Institute Dining Hall

2:00 pm - 3:00 pm
Pierre Hainaut, PhD

Institute for Advanced Biosciences Inserm/CNRS/UGA
Lifetime control of p53 function: walking the ridge trail between degenerative diseases and cancer

3:00 pm - 3:30 pm
    AFTERNOON TEA - Fuld Hall Common Room

3:30 pm - 4:30 pm
David Malkin, MD

The Hospital for Sick Children
    Early detection and prevention of cancer in Li-Fraumeni Syndrome: a multi-pronged approach

4:30 pm - 5:30 pm
Gerard P. Zambetti, PhD

St. Jude Children's Research Hospital
The hypomorphic Brazilian mutant TP53-R337H and variable tumor susceptibility: identification of a potential genetic modifier

 

In partnership with:

Simons Center for Systems Biology                                                                    NJCCR logo

 

 

 

precision medicine at Rutgers Cancer Institute

 

 

 

ScreenNJ

 

 

Donate Now

 

 

 


 

 

 

 

Proud member of
Big Ten Cancer Research Consortium

 

 

Rutgers Health